trastuzumab
astrazeneca,roche,daiichi sankyo
['breast', 'enhertu', 'pivotal', 'astrazeneca']
astrazeneca, daiichi sankyo s enhertu met the primary endpoint of progression-free survival in patients with hr-positive disease in pivotal phase iii trial #asco22 #cancer #oncology #breastcancer 
CRWEWorld's Hottest Stocks Now provides information only. It is not meant to be a recommendation/offer to buy or to sell securities. DYODD